Metabolic adaptation

Weight loss in obese and overweight patients with T2D is consistently accompanied by HbA1c reduction in a dose-dependent manner.

Practitioners can expect a predictable reduction in HbA1c with weight loss in this population.

StrongSupportsmedium confidence

Source linkage for this finding is being attached.

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →